Chandru Subramani

664 total citations
15 papers, 442 citations indexed

About

Chandru Subramani is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Chandru Subramani has authored 15 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Chandru Subramani's work include Hepatitis Viruses Studies and Epidemiology (6 papers), Viral Infections and Outbreaks Research (5 papers) and Hepatitis B Virus Studies (5 papers). Chandru Subramani is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (6 papers), Viral Infections and Outbreaks Research (5 papers) and Hepatitis B Virus Studies (5 papers). Chandru Subramani collaborates with scholars based in India, United States and Japan. Chandru Subramani's co-authors include C. T. Ranjith-Kumar, Milan Surjit, Saumya Anang, S. Shalimar, Baibaswata Nayak, Vidya Padmanabhan Nair, Akriti Srivastava, Tarani Kanta Barman, Sudhanshu Vrati and Ashutosh Tiwari and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Chandru Subramani

13 papers receiving 433 citations

Peers

Chandru Subramani

HEPAT

EPIDE

Kuanhui Xiang China

Gitanjali Subramanya United States

Ranajoy Mullick India

Carina Elsner Germany

Juliano G. Haddad France

Nabil S. Harmal Malaysia

Soonju Park South Korea

Vanessa Fontanes United States

Anna Offersgaard Denmark

Irshad Ur Rehman Pakistan

Kuanhui Xiang China

Chandru Subramani

246 ×1.0

HEPAT

116 ×0.5

273 ×3.7

EPIDE

95 ×1.7

32 ×0.9

Citations per year, relative to Chandru Subramani Chandru Subramani (= 1×) peers Kuanhui Xiang

Countries citing papers authored by Chandru Subramani

Since Specialization

Citations

This map shows the geographic impact of Chandru Subramani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandru Subramani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandru Subramani more than expected).

Fields of papers citing papers by Chandru Subramani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandru Subramani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandru Subramani. The network helps show where Chandru Subramani may publish in the future.

Co-authorship network of co-authors of Chandru Subramani

This figure shows the co-authorship network connecting the top 25 collaborators of Chandru Subramani. A scholar is included among the top collaborators of Chandru Subramani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandru Subramani. Chandru Subramani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Subramani, Chandru, Michelle Meyer, Haiping Hao, et al.. (2025). Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine. Journal of Clinical Investigation. 135(17).

Meyer, Michelle, Bronwyn M. Gunn, Colette Pietzsch, et al.. (2025). Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Nature Communications. 16(1). 5702–5702. 1 indexed citations

Ilinykh, Philipp A., Kai Huang, Bronwyn M. Gunn, et al.. (2024). Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system. Communications Biology. 7(1). 871–871. 3 indexed citations

Subramani, Chandru, et al.. (2023). High content screening strategies for large-scale compound libraries with a focus on high-containment viruses. Antiviral Research. 221. 105764–105764. 3 indexed citations

Subramani, Chandru, et al.. (2023). ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics. 15(4). 1212–1212. 15 indexed citations

Kumar, Amit, et al.. (2023). Hepatitis E Virus Protease Inhibits the Activity of Eukaryotic Initiation Factor 2-Alpha Kinase 4 and Promotes Virus Survival. Journal of Virology. 97(6). e0034723–e0034723.

Subramani, Chandru, et al.. (2022). Avobenzone, Guaiazulene and Tioxolone identified as potent autophagy inducers in a high-throughput image based screen for autophagy flux. SHILAP Revista de lepidopterología. 1(1). 523–536. 7 indexed citations

Dhanjal, Jaspreet Kaur, Vipul Kumar, Sukant Garg, et al.. (2021). Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides. International Journal of Biological Macromolecules. 184. 297–312. 32 indexed citations

Kumar, Vipul, Jaspreet Kaur Dhanjal, Chandru Subramani, et al.. (2021). Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and MortaparibPlus. Bioscience Reports. 41(10). 6 indexed citations

10.

Kumar, Vipul, Jaspreet Kaur Dhanjal, Chandru Subramani, et al.. (2021). Computational and in vitro experimental analyses of the Anti-COVID-19 potential of Mortaparib and MortaparibPlus. Bioscience Reports. 2 indexed citations

11.

Subramani, Chandru, Vidya Padmanabhan Nair, Saumya Anang, et al.. (2018). Host-Virus Protein Interaction Network Reveals the Involvement of Multiple Host Processes in the Life Cycle of Hepatitis E Virus. mSystems. 3(1). 39 indexed citations

12.

Subramani, Chandru, et al.. (2017). A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound. Scientific Reports. 7(1). 5816–5816. 20 indexed citations

13.

Subramani, Chandru, Saumya Anang, S. Shalimar, et al.. (2017). Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase. Journal of Virology. 91(21). 104 indexed citations

14.

Anang, Saumya, Chandru Subramani, Vidya Padmanabhan Nair, et al.. (2016). Identification of critical residues in Hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins. Scientific Reports. 6(1). 25133–25133. 24 indexed citations

15.

Nair, Vidya Padmanabhan, Saumya Anang, Chandru Subramani, et al.. (2016). Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus. PLoS Pathogens. 12(4). e1005521–e1005521. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact